There is a growing body of evidence showing the value of decentralized trials that share real-time data between patients and investigators. Decentralized trials, which utilize mobile apps and the use of connected medical devices, can positively transform
the patient experience, leading to better recruitment and improved study retention. The use of behavioral insights, by means of nudges and reminders, can improve protocol adherence while real-time data sharing can better inform decision making.
During this engaging session, you can expect to learn about:
- Current industry trends and evolving best practices
- Picking providers based on appropriate capabilities
- Analyzing tools, technology and connected devices
- Considering the participant journey and how to design trials with their experience in mind
- Utilizing behavioral nudges
- Other important considerations for designing, conducting, and evaluating decentralized clinical trials
Dawn Anderson
Managing Director, Life Sciences, Deloitte
Dawn is a Managing Director in Deloitte’s Life Sciences practice, and a leader in Deloitte’s Clinical practice. She has more than 30 years of industry experience in Global Pharma and CROs in Clinical Development & Operations, with an emphasis on Clinical Transformation and Digital Clinical Trials. Dawn’s clients span BioPharma, Medtech, CRO, and Academic Research Organizations. Prior to joining Deloitte, Dawn held executive leadership positions at global CROs, BioPharma, and Technology companies.
Ryan Hoffmeister
Managing Director, ConvergeHEALTH
Ryan is a leader in Deloitte’s Life Sciences and Technology practice and leads Portfolio Technology Strategy for the ConvergeHEALTH business unit. In this role, he focuses on leveraging data across the healthcare ecosystem to create improved customer engagement and patient outcomes. His experiences include the scoping, design, and delivery of global Analytics, Digital and Cloud technology programs across advanced patient engagement, pragmatic trials, Real World Data (RWD), CRM, MDM, Patient Services, multi-channel marketing, and HCP Transparency.
Chris Zant
Customer & Marketing Leader for Life Sciences & Healthcare, Deloitte,
Chief Digital Officer, ConvergeHEALTH by Deloitte
Christopher Zant, Customer & Marketing Leader for Life Sciences & Healthcare and Chief Digital Officer of ConvergeHEALTH by Deloitte, helps our clients transform their business through effective and compliant delivery of engaging experiences, digital capabilities, and specialized software solutions. With 27 years of consulting experience, Chris understands the business requirements and enablers that help his clients optimize the patient and health care practitioner experience while streamlining operations and improving performance. Chris excels in using technology to enable engaging experiences and leading clients through complex programs. Chris is passionate about empowering patients to manage their journey through digital technology and is the executive sponsor of the ConvergeHEALTH Connect and MyPATH suites, licensed software platforms which help our clients leverage digital capabilities to develop and strengthen bonds with patients, caregivers, and health care practitioners from research to care delivery.
Kristin Wrobleksi
Real World Evidence Specialist, ConvergeHEALTH by Deloitte, Deloitte Consulting LLP
ConvergeHEALTH creates new health ecosystems to enable the future of health by combining next-generation platforms, deep industry experience, and novel collaboration models. We move with the agility of a health startup, backed by the global reach of Deloitte to design and offer platforms and services that empower the shift to value-based personalized health care. We do this by connecting an ecosystem of digital health and analytics platforms and industry partnerships, and leading advisory and technology services at a global scale, all to put patients at the center of health care.